To this end, we previously described a framework to identify TopBP1 condensate inhibitors to downregulate ATR signaling and consequently, enhance chemotherapy drug effectiveness in colon cancer cells [30]. The gene discussed is TOPBP1; the disease is malignant colon neoplasm.